LeadIQ logo
Learn more at LeadIQ.com

Insights

Recent Acquisition ANI Pharmaceuticals, Inc. recently acquired Alimera Sciences, Inc., expanding its product portfolio and potentially opening new sales channels through the added offerings.

New Product Launches ANI Pharmaceuticals has recently launched new generic drugs like Kionex and Baclofen Oral Suspension, indicating a focus on product innovation that could attract new customers and revenue streams.

Bullish Quarterly Report The bullish quarterly report released by ANI Pharmaceuticals signals positive financial performance, which can be leveraged by sales teams to build confidence among potential clients and investors.

Investment Interest Summit Global Investments' investment of $773,000 in ANI Pharmaceuticals demonstrates external confidence in the company's growth prospects, potentially signaling opportunities for partnership or increased sales.

Competitive Positioning Being identified as a similar company to Perrigo, which has a significant revenue base, presents ANI Pharmaceuticals with a chance to benchmark and identify strategies to further penetrate the market and increase sales.

Similar companies to ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc. Tech Stack

ANI Pharmaceuticals, Inc. uses 8 technology products and services including Akamai, Drupal, web-vitals, and more. Explore ANI Pharmaceuticals, Inc.'s tech stack below.

  • Akamai
    Content Delivery Network
  • Drupal
    Content Management System
  • web-vitals
    Javascript Libraries
  • Webpack
    Miscellaneous
  • Microsoft Teams
    Team Collaboration
  • VMware
    Virtualisation Software
  • Apache HTTP Server
    Web Servers
  • Linkedin
    Widgets

Media & News

ANI Pharmaceuticals, Inc.'s Email Address Formats

ANI Pharmaceuticals, Inc. uses at least 1 format(s):
ANI Pharmaceuticals, Inc. Email FormatsExamplePercentage
first.last@anipharmaceuticals.comJohn.Doe@anipharmaceuticals.com
90%
flast@anipharmaceuticals.comJDoe@anipharmaceuticals.com
5%
last@anipharmaceuticals.comDoe@anipharmaceuticals.com
4%
last.first@anipharmaceuticals.comDoe.John@anipharmaceuticals.com
1%

Frequently Asked Questions

Where is ANI Pharmaceuticals, Inc.'s headquarters located?

Minus sign iconPlus sign iconANI Pharmaceuticals, Inc.'s main headquarters is located at 500 Alexander Park Princeton, New Jersey 08540 US. The company has employees across 4 continents, including North AmericaAsiaEurope.

What is ANI Pharmaceuticals, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact ANI Pharmaceuticals, Inc.'s main corporate office by phone at +1-218-634-3500. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ANI Pharmaceuticals, Inc.'s stock symbol?

Minus sign iconPlus sign iconANI Pharmaceuticals, Inc. is a publicly traded company; the company's stock symbol is ANIP.

What is ANI Pharmaceuticals, Inc.'s official website and social media links?

Minus sign iconPlus sign iconANI Pharmaceuticals, Inc.'s official website is anipharmaceuticals.com and has social profiles on LinkedIn.

How much revenue does ANI Pharmaceuticals, Inc. generate?

Minus sign iconPlus sign icon As of June 2024, ANI Pharmaceuticals, Inc.'s annual revenue reached $750M.

What is ANI Pharmaceuticals, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconANI Pharmaceuticals, Inc.'s SIC code is 2834 - Pharmaceutical Preparations NAICS code is 446110 - Pharmacies and Drug Stores.

How many employees does ANI Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign iconAs of June 2024, ANI Pharmaceuticals, Inc. has approximately 409 employees across 4 continents, including North AmericaAsiaEurope. Key team members include Chief Medical Officer: M. P.Chief Compliance Officer And Head Of Legal, Rare Disease: E. P.Vice President Of Product Development: E. D.. Explore ANI Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does ANI Pharmaceuticals, Inc. belong to?

Minus sign iconPlus sign iconANI Pharmaceuticals, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does ANI Pharmaceuticals, Inc. use?

Minus sign iconPlus sign iconANI Pharmaceuticals, Inc.'s tech stack includes AkamaiDrupalweb-vitalsWebpackMicrosoft TeamsVMwareApache HTTP ServerLinkedin.

What is ANI Pharmaceuticals, Inc.'s email format?

Minus sign iconPlus sign iconANI Pharmaceuticals, Inc.'s email format typically follows the pattern of . Find more ANI Pharmaceuticals, Inc. email formats with LeadIQ.

How much funding has ANI Pharmaceuticals, Inc. raised to date?

Minus sign iconPlus sign icon As of June 2024, ANI Pharmaceuticals, Inc. has raised $75M in funding. The last funding round occurred on May 05, 2023.
ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc.

Pharmaceutical ManufacturingNew Jersey, United States501-1000 Employees

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by scaling up our Rare Disease business through the successful launch of our lead asset, Purified Cortrophin® Gel, strengthening our generics business with enhanced research and development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.

Section iconCompany Overview

Headquarters
500 Alexander Park Princeton, New Jersey 08540 US
Phone number
+1-218-634-3500
Website
anipharmaceuticals.com
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
ANIP
NAICS Code
446110 - Pharmacies and Drug Stores
Employees
501-1000

Section iconMedia & News

Section iconFunding & Financials

  • $75M

    ANI Pharmaceuticals, Inc. has raised a total of $75M of funding over 3 rounds. Their latest funding round was raised on May 05, 2023.

  • $100M$1B

    ANI Pharmaceuticals, Inc.'s revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $75M

    ANI Pharmaceuticals, Inc. has raised a total of $75M of funding over 3 rounds. Their latest funding round was raised on May 05, 2023.

  • $100M$1B

    ANI Pharmaceuticals, Inc.'s revenue is in the range of $100M$1B

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.